Log in to save to my catalogue

Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus

Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2598100917

Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus

About this item

Full title

Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus

Publisher

United States: Public Library of Science

Journal title

PLoS pathogens, 2021-10, Vol.17 (10), p.e1009858

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Autoimmune diseases are often treated by glucocorticoids and immunosuppressive drugs that could increase the risk for infection, which in turn deteriorate disease and cause mortality. Low-dose IL-2 (Ld-IL2) therapy emerges as a new treatment for a wide range of autoimmune diseases. To examine its influence on infection, we retrospectively studied 6...

Alternative Titles

Full title

Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2598100917

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2598100917

Other Identifiers

ISSN

1553-7374,1553-7366

E-ISSN

1553-7374

DOI

10.1371/journal.ppat.1009858

How to access this item